Coursera (COUR) Expected to Announce Quarterly Earnings on Thursday

Coursera (NYSE:COUR) will likely be releasing its Q4 2025 results after the market closes on Thursday, February 5th. Analysts expect Coursera to post earnings of $0.06 per share and revenue of $191.8330 million for the quarter. Individuals may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Thursday, February 5, 2026 at 5:00 PM ET.

Coursera Stock Performance

Shares of COUR stock opened at $5.86 on Wednesday. The firm’s 50 day moving average price is $7.28 and its two-hundred day moving average price is $9.35. Coursera has a 52-week low of $5.76 and a 52-week high of $13.56. The stock has a market cap of $974.27 million, a PE ratio of -20.19 and a beta of 1.37.

Analysts Set New Price Targets

A number of equities research analysts recently commented on COUR shares. JPMorgan Chase & Co. raised Coursera from a “neutral” rating to an “overweight” rating and set a $12.00 price objective for the company in a research note on Wednesday, December 17th. Wall Street Zen upgraded Coursera from a “hold” rating to a “buy” rating in a report on Sunday, January 25th. Telsey Advisory Group restated an “outperform” rating and set a $14.00 target price on shares of Coursera in a research report on Friday, January 30th. UBS Group cut their price target on shares of Coursera from $11.00 to $9.00 and set a “neutral” rating on the stock in a research report on Thursday, December 18th. Finally, Needham & Company LLC reissued a “buy” rating and set a $14.00 price objective on shares of Coursera in a research note on Wednesday, November 26th. Seven investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $12.27.

Insider Activity

In related news, SVP Alan B. Cardenas sold 8,078 shares of the stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $8.17, for a total transaction of $65,997.26. Following the completion of the sale, the senior vice president directly owned 237,828 shares of the company’s stock, valued at approximately $1,943,054.76. This represents a 3.28% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 16.80% of the company’s stock.

Institutional Trading of Coursera

Institutional investors have recently made changes to their positions in the business. CIBC Bancorp USA Inc. bought a new position in Coursera in the third quarter valued at $173,000. Oberweis Asset Management Inc. bought a new position in shares of Coursera in the 3rd quarter valued at about $6,569,000. PharVision Advisers LLC acquired a new stake in shares of Coursera in the third quarter valued at about $272,000. XTX Topco Ltd raised its holdings in Coursera by 59.3% during the third quarter. XTX Topco Ltd now owns 82,497 shares of the company’s stock worth $966,000 after acquiring an additional 30,702 shares in the last quarter. Finally, Voleon Capital Management LP acquired a new position in Coursera during the third quarter valued at approximately $190,000. Institutional investors own 89.55% of the company’s stock.

Coursera Company Profile

Coursera, Inc (NYSE:COUR) operates a leading online learning platform that delivers courses, specializations, professional certificates and fully accredited degree programs in collaboration with top universities and industry partners. Founded in 2012 by Stanford University professors Andrew Ng and Daphne Koller, Coursera’s mission is to provide universal access to world-class education and bridge skill gaps in a rapidly evolving job market.

The platform features more than 6,000 offerings created by over 275 academic institutions and corporate entities, spanning fields such as data science, business, technology, health care and the arts.